ZTOX Insights

GLEN

GLEN

Jun 4, 2026 · 1 min read

Market Updates Corporate announcement

Glen Industries (GLEN): Company Update

Company Update Transcript of the discussion on the Audited Financial statement (Consolidated and Standalone) of the company for the half year ended and financial year ended March 31, 2026 at the analyst meet held on May 29, 2026 is attached and also available on the website of the company. Transcript of the discussion on the Audited Financial statement (Consolidated and Standalone) of the company for the half year ended and financial year ended March 31, 2026 at the analyst meet held on May

Read article

GLENMARK

GLENMARK

Jun 4, 2026 · 1 min read

Market Updates Corporate announcement

Glenmark Pharmaceuticals (GLENMARK): Investor Presentation

Investor Presentation Glenmark Pharmaceuticals Limited has informed the Exchange about Investor Presentation Glenmark Pharmaceuticals Limited has informed the Exchange about Investor Presentation

Read article

GLENMARK

GLENMARK

Jun 4, 2026 · 1 min read

Market Updates Corporate announcement

Glenmark Pharmaceuticals (GLENMARK): Company Update

Company Update Investor Presentation - Q4 FY 25-26 Investor Presentation - Q4 FY 25-26

Read article

GLENMARK

GLENMARK

Jun 4, 2026 · 1 min read

Market Updates Corporate announcement

Glenmark Pharmaceuticals (GLENMARK): General Updates

General Updates The Board of Directors, at its meeting held today, has approved the transfer of the Company's Nebulizer brands/IP portfolio to Glenmark Healthcare Limited ( GHL ), a wholly owned subsidiary of the Company. The Board of Directors, at its meeting held today, has approved the transfer of the Company's Nebulizer brands/IP portfolio to Glenmark Healthcare Limited ( GHL ), a wholly owned subsidiary of the Company. The Board of Directors, at its meeting held today, has approved the t

Read article

GLENMARK

GLENMARK

Jun 4, 2026 · 1 min read

Market Updates Corporate announcement

Glenmark Pharmaceuticals (GLENMARK): General Updates

General Updates The Board of Directors, at its meeting held today, has approved the transfer of the Company's Nebulizer brands/IP portfolio to Glenmark Healthcare Limited ( GHL ), a wholly owned subsidiary of the Company. The Board of Directors, at its meeting held today, has approved the transfer of the Company's Nebulizer brands/IP portfolio to Glenmark Healthcare Limited ( GHL ), a wholly owned subsidiary of the Company. The Board of Directors, at its meeting held today, has approved the t

Read article

GLENMARK

GLENMARK

Jun 4, 2026 · 1 min read

Market Updates Corporate announcement

Glenmark Pharmaceuticals (GLENMARK): Corp. Action

Corp. Action The Board has recommended dividend of Rs. 2.5/- per share (face value of Re. 1/- each) on the equity shares of the Company for FY 2025-26 subject to the approval of the Shareholders at the ensuing Annual General Meeting. The Board has recommended dividend of Rs. 2.5/- per share (face value of Re. 1/- each) on the equity shares of the Company for FY 2025-26 subject to the approval of the Shareholders at the ensuing Annual General Meeting. The Board has recommended dividend of Rs.

Read article

GLENMARK

GLENMARK

Jun 4, 2026 · 1 min read

Market Updates Corporate announcement

Glenmark Pharmaceuticals (GLENMARK): Corp. Action

Corp. Action The Board has recommended dividend of Rs. 2.5/- per share (face value of Re. 1/- each) on the equity shares of the Company for FY 2025-26 subject to the approval of the Shareholders at the ensuing Annual General Meeting. The Board has recommended dividend of Rs. 2.5/- per share (face value of Re. 1/- each) on the equity shares of the Company for FY 2025-26 subject to the approval of the Shareholders at the ensuing Annual General Meeting. The Board has recommended dividend of Rs.

Read article

GLENMARK

GLENMARK

Jun 4, 2026 · 1 min read

Market Updates Corporate announcement

Glenmark Pharmaceuticals (GLENMARK): Corp. Action

Corp. Action The Board has recommended dividend of Rs. 2.5/- per share (face value of Re. 1/- each) on the equity shares of the Company for FY 2025-26 subject to the approval of the Shareholders at the ensuing Annual General Meeting. The Board has recommended dividend of Rs. 2.5/- per share (face value of Re. 1/- each) on the equity shares of the Company for FY 2025-26 subject to the approval of the Shareholders at the ensuing Annual General Meeting. The Board has recommended dividend of Rs.

Read article

GLENMARK

GLENMARK

Jun 4, 2026 · 1 min read

Market Updates Corporate announcement

Glenmark Pharmaceuticals (GLENMARK): Dividend

Dividend Glenmark Pharmaceuticals Limited has informed the Exchange that Board of Directors at its meeting held on May 29, 2026, recommended Final Dividend of Rs. 2.5 per equity share. Glenmark Pharmaceuticals Limited has informed the Exchange that Board of Directors at its meeting held on May 29, 2026, recommended Final Dividend of Rs. 2.5 per equity share. Glenmark Pharmaceuticals Limited has informed the Exchange that Board of Directors at its meeting held on May 29, 2026, recommended Fina

Read article

GLENMARK

GLENMARK

Jun 4, 2026 · 1 min read

Market Updates Corporate announcement

Glenmark Pharmaceuticals (GLENMARK): Dividend

Dividend Glenmark Pharmaceuticals Limited has informed the Exchange that Board of Directors at its meeting held on May 29, 2026, recommended Final Dividend of Rs. 2.5 per equity share. Glenmark Pharmaceuticals Limited has informed the Exchange that Board of Directors at its meeting held on May 29, 2026, recommended Final Dividend of Rs. 2.5 per equity share. Glenmark Pharmaceuticals Limited has informed the Exchange that Board of Directors at its meeting held on May 29, 2026, recommended Fina

Read article

GLENMARK

GLENMARK

Jun 4, 2026 · 1 min read

Market Updates Corporate announcement

Glenmark Pharmaceuticals (GLENMARK): Dividend

Dividend Glenmark Pharmaceuticals Limited has informed the Exchange that Board of Directors at its meeting held on May 29, 2026, recommended Final Dividend of Rs. 2.5 per equity share. Glenmark Pharmaceuticals Limited has informed the Exchange that Board of Directors at its meeting held on May 29, 2026, recommended Final Dividend of Rs. 2.5 per equity share. Glenmark Pharmaceuticals Limited has informed the Exchange that Board of Directors at its meeting held on May 29, 2026, recommended Fina

Read article

GLENMARK

GLENMARK

Jun 4, 2026 · 1 min read

Market Updates Corporate announcement

Glenmark Pharmaceuticals (GLENMARK): Outcome of Board Meeting

Outcome of Board Meeting Glenmark Pharmaceuticals Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026. Glenmark Pharmaceuticals Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026.

Read article

GLENMARK

GLENMARK

Jun 4, 2026 · 1 min read

Market Updates Corporate announcement

Glenmark Pharmaceuticals (GLENMARK): Outcome of Board Meeting

Outcome of Board Meeting Glenmark Pharmaceuticals Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026. Glenmark Pharmaceuticals Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026.

Read article